Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002077.SZ Stock Summary
Top 10 Correlated ETFs
002077.SZ
In the News
002077.SZ Financial details
Company Rating
Neutral
Market Cap
7.65B
Income
129.13M
Revenue
501.3M
Book val./share
5.68
Cash/share
-0.86
Dividend
-
Dividend %
-
Employees
831
Optionable
No
Shortable
Yes
Earnings
28 Apr 2021
P/E
63.91
Forward P/E
-
PEG
-156.38
P/S
16.18
P/B
2.51
P/C
-14.2
P/FCF
-128.37
Quick Ratio
-0.57
Current Ratio
1.44
Debt / Equity
0.14
LT Debt / Equity
0.07
-
-
EPS (TTM)
0.22
EPS next Y
-
EPS next Q
-
EPS this Y
-52.17%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-19.56%
Revenue Q/Q
44.92%
EPS Q/Q
-18.03%
-
-
-
-
SMA20
-14.54%
SMA50
-11.85%
SMA100
-25.56%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
4%
ROC
0.04%
Gross Margin
12%
Oper. Margin
31%
Profit Margin
26%
Payout
33%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
11.64-18.5
52W High
-32.17%
52W Low
+11%
RSI
33.39
Rel Volume
0.25
Avg Volume
22.92M
Volume
5.64M
Perf Week
-7.71%
Perf Month
-20.25%
Perf Quarter
-26.22%
Perf Half Y
-21.43%
-
-
-
-
Beta
0.158
-
-
Volatility
0.45%, 1%
Prev Close
-2.4%
Price
12.21
Change
-3.86%
002077.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.91 | 1.61 | 1.48 | 1.18 | 0.98 | |
Net income per share | -0.98 | -0.81 | 0.17 | 0.23 | 0.11 | |
Operating cash flow per share | 0.26 | 0.54 | 0.57 | 0.54 | 0.18 | |
Free cash flow per share | 0.03 | 0.41 | 0.43 | 0.32 | -0.12 | |
Cash per share | 0.07 | 0.45 | -0.62 | 0.99 | 3.45 | |
Book value per share | 5.67 | 4.84 | 5.12 | 5.39 | 5.47 | |
Tangible book value per share | 4.95 | 4.75 | 5.07 | 5.58 | 5.7 | |
Share holders equity per share | 5.67 | 4.84 | 5.12 | 5.39 | 5.47 | |
Interest debt per share | 4.39 | 3.93 | 1.82 | 1.19 | 1.01 | |
Market cap | 2.21B | 3.45B | 3.84B | 4.45B | 10.78B | |
Enterprise value | 3.64B | 4.53B | 4.39B | 4.64B | 10.94B | |
P/E ratio | -3.88 | -7.32 | 39.25 | 32.7 | 164.87 | |
Price to sales ratio | 1.31 | 3.7 | 4.47 | 6.51 | 18.93 | |
POCF ratio | 14.67 | 11.05 | 11.55 | 14.33 | 100.42 | |
PFCF ratio | 145.79 | 14.34 | 15.52 | 24.2 | -151.15 | |
P/B Ratio | 0.67 | 1.23 | 1.29 | 1.42 | 3.39 | |
PTB ratio | 0.67 | 1.23 | 1.29 | 1.42 | 3.39 | |
EV to sales | 2.15 | 4.86 | 5.1 | 6.78 | 19.22 | |
Enterprise value over EBITDA | 32.95 | 16.9 | 11.84 | 15.13 | 43.41 | |
EV to operating cash flow | 24.15 | 14.5 | 13.19 | 14.93 | 101.93 | |
EV to free cash flow | 240.02 | 18.82 | 17.73 | 25.2 | -153.42 | |
Earnings yield | -0.26 | -0.14 | 0.03 | 0.03 | 0.01 | |
Free cash flow yield | 0.01 | 0.07 | 0.06 | 0.04 | -0.01 | |
Debt to equity | 0.74 | 0.75 | 0.33 | 0.21 | 0.18 | |
Debt to assets | 0.34 | 0.38 | 0.22 | 0.15 | 0.13 | |
Net debt to EBITDA | 12.94 | 4.02 | 1.48 | 0.6 | 0.64 | |
Current ratio | 1.16 | 1.65 | 1.12 | 1.57 | 1.39 | |
Interest coverage | -5.6 | 0.45 | 2.9 | 3.84 | 3.45 | |
Income quality | -0.26 | -0.66 | 2.65 | 1.97 | 1.64 | |
Dividend Yield | 0.07 | 0.04 | 0.02 | 0.01 | 0 | |
Payout ratio | -0.27 | -0.3 | 0.82 | 0.3 | 0.39 | |
Sales general and administrative to revenue | 0.01 | 0.03 | 0.02 | 0.03 | 0.04 | |
Research and developement to revenue | 0.02 | 0.04 | 0.04 | 0.06 | 0.06 | |
Intangibles to total assets | 0.06 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | -0.9 | -0.23 | -0.26 | -0.41 | -1.66 | |
Capex to revenue | -0.08 | -0.08 | -0.1 | -0.19 | -0.31 | |
Capex to depreciation | -0.66 | -0.37 | -0.75 | -0.89 | -1.14 | |
Stock based compensation to revenue | 0 | 0.03 | 0 | 0 | 0.03 | |
Graham number | 11.2 | 9.41 | 4.41 | 5.33 | 3.72 | |
ROIC | -0.1 | 0.01 | 0.06 | 0.04 | 0.03 | |
Return on tangible assets | -0.08 | -0.09 | 0.02 | 0.03 | 0.02 | |
Graham Net | -3.49 | -1.15 | -2.25 | -0.31 | 2.3 | |
Working capital | 550.09M | 1.42B | 122.2M | 398.38M | 253.49M | |
Tangible asset value | 2.87B | 2.76B | 2.94B | 3.24B | 3.31B | |
Net current asset value | 103.72M | 866.91M | -266.93M | 23.66M | -78.24M | |
Invested capital | 0.74 | 0.75 | 0.33 | 0.21 | 0.18 | |
Average receivables | 1.42B | 1.84B | 1.32B | 368.33M | 271.57M | |
Average payables | 811.6M | 658.2M | 320.67M | 253.58M | 227.93M | |
Average inventory | 1.63B | 869.89M | 275.44M | 233.19M | 231.39M | |
Days sales outstanding | 323.95 | 855.54 | 195.99 | 146.67 | 172.11 | |
Days payables outstanding | 208.92 | 141.36 | 189.55 | 179.79 | 178.48 | |
Days of inventory on hand | 315.84 | 119.85 | 165.82 | 174.09 | 190.73 | |
Receivables turnover | 1.13 | 0.43 | 1.86 | 2.49 | 2.12 | |
Payables turnover | 1.75 | 2.58 | 1.93 | 2.03 | 2.05 | |
Inventory turnover | 1.16 | 3.05 | 2.2 | 2.1 | 1.91 | |
ROE | -0.17 | -0.17 | 0.03 | 0.04 | 0.02 | |
Capex per share | -0.23 | -0.12 | -0.15 | -0.22 | -0.31 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.24 | 0.29 | 0.21 | 0.15 | 0.22 | |
Net income per share | 0 | 0.02 | 0.13 | 0.04 | 0.03 | |
Operating cash flow per share | 0 | 0.02 | 0.13 | 0.09 | -0.07 | |
Free cash flow per share | -0.1 | -0.12 | 0.06 | 0.05 | -0.09 | |
Cash per share | -0.38 | 3.45 | -0.67 | -0.82 | -0.86 | |
Book value per share | 5.03 | 5.47 | 5.61 | 5.64 | 5.68 | |
Tangible book value per share | 5.22 | 5.7 | 5.59 | 5.63 | 5.64 | |
Share holders equity per share | 5.03 | 5.47 | 5.61 | 5.64 | 5.68 | |
Interest debt per share | 0.88 | 0.98 | 0.88 | 0.78 | 0.81 | |
Market cap | 7.35B | 10.78B | 9.58B | 8.68B | 8.65B | |
Enterprise value | 7.46B | 10.94B | 9.8B | 8.9B | 8.92B | |
P/E ratio | 939.36 | 193.49 | 31.27 | 101.97 | 124.43 | |
Price to sales ratio | 48.74 | 64.96 | 78.53 | 99.55 | 68.51 | |
POCF ratio | 3.76K | 773.98 | 125.09 | 163.05 | -228.85 | |
PFCF ratio | -117.64 | -156.55 | 295.1 | 320.64 | -160.63 | |
P/B Ratio | 2.32 | 3.39 | 2.94 | 2.65 | 2.63 | |
PTB ratio | 2.32 | 3.39 | 2.94 | 2.65 | 2.63 | |
EV to sales | 49.49 | 65.94 | 80.4 | 102.07 | 70.64 | |
Enterprise value over EBITDA | 237.83 | 406.32 | 95.82 | 313.11 | 466.45 | |
EV to operating cash flow | 3.82K | 785.59 | 128.06 | 167.18 | -235.97 | |
EV to free cash flow | -119.46 | -158.9 | 302.11 | 328.76 | -165.63 | |
Earnings yield | 0 | 0 | 0.01 | 0 | 0 | |
Free cash flow yield | -0.01 | -0.01 | 0 | 0 | -0.01 | |
Debt to equity | 0.17 | 0.18 | 0.16 | 0.14 | 0.14 | |
Debt to assets | 0.13 | 0.13 | 0.12 | 0.11 | 0.11 | |
Net debt to EBITDA | 3.63 | 6.01 | 2.22 | 7.73 | 14.07 | |
Current ratio | 1.6 | 1.39 | 1.46 | 1.51 | 1.44 | |
Interest coverage | 4.84 | 0.64 | 14.75 | 4.23 | 4.28 | |
Income quality | 1 | 1 | 1 | 2.5 | -2.17 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 3.07 | 0.43 | 0.08 | 0.71 | 0.85 | |
Sales general and administrative to revenue | 0.26 | -0.17 | 0.11 | -0.06 | 0.21 | |
Research and developement to revenue | 0.05 | 0.06 | 0.07 | 0.06 | 0.04 | |
Intangibles to total assets | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -32.94 | -5.94 | -0.58 | -0.49 | 0.42 | |
Capex to revenue | -0.43 | -0.5 | -0.36 | -0.3 | -0.13 | |
Capex to depreciation | -1.44 | -1.85 | -1.15 | -0.68 | 0.23 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.59 | 1.72 | 4.08 | 2.16 | 1.96 | |
ROIC | 0 | 0 | 0.02 | 0.01 | 0 | |
Return on tangible assets | 0 | 0 | 0.02 | 0.01 | 0 | |
Graham Net | -1.35 | 2.3 | -1.58 | -1.65 | -1.69 | |
Working capital | 359.52M | 253.49M | 223.72M | 219.35M | 201.88M | |
Tangible asset value | 3.29B | 3.31B | 3.24B | 3.27B | 3.27B | |
Net current asset value | 17.86M | -78.24M | -84.32M | -94.52M | -101.94M | |
Invested capital | 0.17 | 0.18 | 0.16 | 0.14 | 0.14 | |
Average receivables | 264.56M | 272.17M | 241.7M | 211.44M | 221.45M | |
Average payables | 201.22M | 203.24M | 199.34M | 180.88M | 180.21M | |
Average inventory | 236.96M | 231.73M | 218.44M | 203.4M | 206.91M | |
Days sales outstanding | 164.74 | 145.63 | 158.66 | 214.69 | 167.44 | |
Days payables outstanding | 150.72 | 144.56 | 151.83 | 189.4 | 145.94 | |
Days of inventory on hand | 183.72 | 154.49 | 171.11 | 212.49 | 171.22 | |
Receivables turnover | 0.55 | 0.62 | 0.57 | 0.42 | 0.54 | |
Payables turnover | 0.6 | 0.62 | 0.59 | 0.48 | 0.62 | |
Inventory turnover | 0.49 | 0.58 | 0.53 | 0.42 | 0.53 | |
ROE | 0 | 0 | 0.02 | 0.01 | 0.01 | |
Capex per share | -0.1 | -0.14 | -0.08 | -0.05 | -0.03 |
002077.SZ Frequently Asked Questions
What is Jiangsu Dagang Co., Ltd. stock symbol ?
Jiangsu Dagang Co., Ltd. is a CN stock and trading under the symbol 002077.SZ
What is Jiangsu Dagang Co., Ltd. stock quote today ?
Jiangsu Dagang Co., Ltd. stock price is $12.21 today.
Is Jiangsu Dagang Co., Ltd. stock public?
Yes, Jiangsu Dagang Co., Ltd. is a publicly traded company.